Table 2.
Mushrooms (Common Name) |
Bioactive Compounds | Type of Study | Gut Bacteria Effects | References |
---|---|---|---|---|
Lentinula edodes (Shiitake) |
Lentinula edodes soluble dietary fiber fractions (LESDF): LESDF-1: →6)-β-D-Glcp-(1→,→4)-β-D-Glcp-(1→,→5)-β-D-Arap-(1→,→4)-β-D-Xylp-(1→,→4)-α-D-Manp,→3)-α-L-Rhap-(1→,→6)-β-D-Galp-(1→ LESDF-2: →6)-β-D-Glcp-1→,→4)-α-D-Glcp-(1→,β-DGlcp-(1→,→5)-β-D-Arap-(1→,→2)-α-L-Rhap-(1→,→3,6)-α-D-Manp-(1→,→6)-β-D-Galp-(1→,→4)-β-D-Xylp-(1→ LESDF-3: β-D-Arap-(1→,→3)-α-D-Galp-(1→,→3,6)-α-D-Manp-(1→, →4)- β-D-Xylp-(1→, and →2,4)-α-D-Glcp-(1→ |
Human gut microbiota in vitro study |
LEDS-2 increase microbial communities LEDS-3 causes an increase in the abundance of Parasutterella, Bacteroides, Parabacteroides and Lachnospira | [42,49,50] |
Auricularia auricula-judae (wood ear) Flammulina velutipes (velvet shank) |
Mushrooms dried powder after in vitro digestion with α-amylase, pepsin, and pancreatin. The main bioactive compounds are carbohydrates and proteins. | Human gut microbiota in vitro study |
They led to an increase in the abundance of groups of Actinobacteria, Bacteroidetes, Proteobacteria and inhibited the growth of Fusobacteria and Firmicutes |
[51] |
Lentinus edodes Pleurotus eryngii (King Oyster) |
Promoted the growth of Bacteroidetes, Actinobacteria and inhibited the development of Proteobacteria, Fusobacteria, and Firmicutes |
|||
Pleurotus osteratus (Oyster mushroom) | Promoted the growth of Actinobacteria, Bacteroidetes, and Fusobacteria, inhibited the growth of Proteobacteria and Firmicutes. |
|||
Agaricus bispours (champigno n) | Positively influences Actinobacteria, Fusobacteria, and Firmicutes and inhibit the growth of Bacteroidetes and Proteobacteria |
|||
Hericium erinaceus (lion’s mane mushroom) |
Polysaccharides, alcoholic extracts, and whole extracts alcoholic extracts, and whole extracts | Rats with inflammatory bowel disease |
Reduce the amount of lipopolysaccharide toxins, increase the abundance of Bifidobacterium; | [25,52] |
Oudemansiella radicata (Rooted Collybia) |
Polysaccharide extract | Human gut microbiota in vitro study |
Reduce the Firmicutes/Bacteroidetes ratio Increase Bacteroides abundance |
[53] |
Ophicordyceps sinensis (Rooted Collybia) | Mushrooms dried powder after in vitro digestion with α-amylase, pepsin, and pancreatin | Human gut microbiota in vitro study |
Increase abundance of Bifidobacteriales, Selenomonadales | [54] |
Cordyceps militaris (Chinese caterpillar fungus) |
Increase the relative abundance Bacteroidales. Implicitly decreasing the ratio of Firmicutes/Bacteroidetes ratio |
|||
Inonotus obliquus (chaga) |
Polysaccharides Ethanolic extract |
High-fat diet mice (HFD-mice) |
Increase Akkermansia abundance and fatty acid elongation |
[55] |
Phellinus linteus (black hoof mushroom) | Polysaccharide total extract (two fractions were characterized, PLPS-1: α-D-glucose (1→4)-α-D-glucose (1→6) units and PLPS-2: α-(1→3)- D-glucose and α-(1→6)-D-glucose) |
Sprague Dawley rats with Type 2 diabetes |
Causes an increase in the abundance of Lachnospiraceae-NK4A1 36, Blautia, Ruminiclostridium-9, Eubacterium xylanophilum, Anaerotruncus, Oscillibacter Lachnospiraceae-UCG-00 6, Roseburia, Prevotella and improves microbial balance |
[56,57] |
Cordycepssinensis (Cordyceps mushroom) |
Polysaccharide fraction | HFD mice |
The relative abundances of Actinobacteria (in particular Olsenella bacteria) and Acidobacterias were increased and those of Bacteroidetes decreased. At the genus/cluster level, decreases of Barnesiella, Prevotellaceae and the Lachnospiraceae incertae sedis and increases of Christensenella, Clostridium_XVIII cluster and Pseudomonas |
[58] |
Pleurotus
eryngii |
Soluble polysaccharide fraction | HFD mice | Supplementation causes changes only at the genus level, an increase of Anaerostipes, Clostridium, Lactococcus, and a decrease of Roseburia and Lactobacillus |
[59] |